Zydus Lifesciences has informed that it enclosed a copy of press release dated August 31, 2023 titled ‘Zydus receives final approval from the USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg’.
The above information is a part of company’s filings submitted to BSE.